<DOC>
	<DOCNO>NCT01606111</DOCNO>
	<brief_summary>The purpose trial investigate safety efficacy Cerebrolysin add-on therapy standard care patient acute traumatic brain injury ( TBI ) . The study duration patient 180 day .</brief_summary>
	<brief_title>The CAPTAIN Trial : Cerebrolysin Asian Pacific Trial Acute Brain Injury Neurorecovery</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Cerebrolysin</mesh_term>
	<criteria>Clinical diagnosis TBI GCS 712 Only isolated TBI CT PreTrauma KarnofskyIndex = 100 Age 1860 year Male female patient Time needle study medication within 6 hour injury Patient pregnant lactate trial childbearing potential Patient able speak , read write predefined study language accident . Reasonable expectation completion outcome measure followup Written inform consent Evidence preexist major health problem Any neurological nonneurological condition independent TBI might influence functional outcome efficacy outcome measure Injury write hand influence cognitive outcome measure Clear clinical sign intoxication influence evaluation Major drug dependency include alcohol Chronic treatment steroid , Ca2+channel blockers major anticoagulant Penetrating highvelocity missile head trauma Stab wound trauma brain Patients spinal cord injury</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>